Skip to content

Cytokine Response to Abdominal Wall Reconstruction

Pilot Study of Systemic Inflammatory and Transcriptomic Responses in Patients Undergoing Open Retromuscular Ventral Hernia Repair

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07422584
Enrollment
25
Registered
2026-02-20
Start date
2026-02-03
Completion date
2027-03-05
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Ventral Hernia

Brief summary

This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure. The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.

Detailed description

Major abdominal wall reconstruction (AWR) for large ventral hernias is among the most physiologically demanding procedures performed in general surgery. These patients often have a history of multiple prior abdominal operations, chronically altered abdominal wall mechanics and significant loss of domain. Reduction of visceral contents and abdominal wall reconstruction frequently require high-tension closure, resulting in an abrupt increase in intra-abdominal pressure (IAP) that impairs diaphragmatic excursion, reduces splanchnic perfusion, causes renal venous congestion and induces global physiologic stress. Consequently, these patients face a high risk of postoperative complications including respiratory failure, renal dysfunction, and prolonged intensive care unit (ICU) stays. A critical gap in AWR research is the lack of characterization of the biologic inflammatory and cytokine responses associated with high-tension abdominal wall closure. This gap stands in contrast to robust evidence from the trauma and critical care literature demonstrating that cytokine activation correlates with injury severity and contributes to organ dysfunction and postoperative morbidity. Defining the inflammatory and cytokine signaling pathways activated during high-tension closure would provide a framework to inform operative planning and perioperative management, particularly in patients with significant comorbidities who may be less tolerant to postoperative physiologic stress. These insights would enable validation of current techniques and establish the foundation for future interventional trials targeting inflammatory pathways to improve postoperative outcomes. The Digestive Health Institute at Northwestern University is uniquely positioned to support this translational research, bridging surgical physiology, inflammation, and patient outcomes. The investigators hypothesize that: 1. Major abdominal wall reconstruction induces a trauma-like systemic inflammatory response characterized by elevations in GM-CSF, IFN-Gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha with a concomitant decrease in the anti-inflammatory cytokines, IL-4 and IL-10. 2. Increased intra-abdominal pressure (IAP) following high-tension closure amplifies cytokine activation and is associated with early postoperative organ dysfunction and increased postoperative complications.

Interventions

OTHERNot applicable- observational study

There are no interventions in this observational study.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Surgical Participants * Adults aged 18 years or older * Scheduled to undergo open retromuscular ventral hernia repair * Able to provide written informed consent Healthy Control Participants * Adults aged 18 years or older * No known inflammatory, autoimmune, or immunologic disease * Able to provide written informed consent

Exclusion criteria

* Emergent or urgent cases * Pregnancy * Chronic systemic steroid use or immunosuppressive therapy * Active infection at the time of enrollment * Known autoimmune or inflammatory disease * End-stage organ failure * Abdominal surgery within the preceding 60 days

Design outcomes

Primary

MeasureTime frameDescription
Determine whether fascial closure tension correlates with systemic and peritoneal fluid cytokine activation.Baseline through postoperative day 5Blood and peritoneal fluid will be collected at baseline (intra-operative), immediately following fascial closure and on postoperative days 1, 3, and 5. Serum cytokine concentrations of GM-CSF, IFN-gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha (inflammatory); IL-4 and IL-10 (anti-inflammatory) will be measured via multiplex immunoassays (Luminex). Cytokine area under the curve will also be calculated to allow analysis of total cytokine exposure over time.

Secondary

MeasureTime frameDescription
Differences in peripheral blood mononuclear cells and peritoneal macrophage transcriptomic signatures via bulk RNA sequencing between baseline profiles from healthy control subjects, high-tension and low-tension abdominal wall closures.Baseline through postoperative day 5Peripheral blood mononuclear cells (PBMCs) and peritoneal macrophages will be isolated at baseline, immediately following fascial closure and on postoperative days 1, 3, and 5. Bulk RNA sequencing will be performed. Differentially expressed genes will be determined and KEGG and GO pathway analyses performed.
Differences in peak intra-abdominal values, intra-abdominal hypertension grading, abdominal perfusion pressure, plateau pressure between baseline profiles from healthy control subjects, high-tension and low-tension abdominal wall closures.Baseline through postoperative day 5Intra-abdominal pressure (IAP) will be assessed using bladder pressure measurements, along with plateau pressure and abdominal perfusion pressure (APP) - calculated as mean arterial pressure (MAP) minus IAP. Measurements will be obtained at baseline, POD1, POD3 and POD5. Measures will include peak IAP, and duration of intra-abdominal hypertension (IAH), defined as IAP \>12mmHg. Peak serum cytokine levels will be correlated with peak IAP using Spearman correlation and multivariable linear regression.
Incidence of respiratory compromiseFrom surgery through hospital discharge (up to 30 days)Respiratory compromise defined as failure to wean from mechanical ventilation or development of postoperative pneumonia.
Incidence of acute kidney injuryFrom surgery through hospital discharge (up to 30 days)Acute kidney injury defined as increase in serum creatinine to \>1.5 times baseline with urine output \<0.5 mL/kg/hr for 6 hours.
Incidence of vasopressor useFrom surgery through hospital discharge (up to 30 days)Requirement for vasopressor support postoperatively.
Incidence of postoperative ileusFrom surgery through hospital discharge (up to 30 days)Development of postoperative ileus as documented in the medical record.
Incidence of wound complicationsFrom surgery through hospital discharge (up to 30 days)Development of surgical site infection or wound dehiscence
ICU length of stayFrom surgery through hospital discharge (up to 30 days)Number of days in the intensive care unit following surgery.
Hospital length of stayFrom surgery through hospital discharge (up to 30 days)Total number of days hospitalized following surgery.

Countries

United States

Contacts

CONTACTMegan Melland-Smith, MD
megan.mellandsmith@nm.org312-907-1414
CONTACTNancy Ly, MD
nancy.ly@nm.org262-455-1560
STUDY_DIRECTORMichael Rosen, MD

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026